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a b s t r a c t
Synthetic amorphous silica nanoparticles (SAS NPs) have been used in various industries, such as plastics, glass, paints, electronics, synthetic rubber, in pharmaceutical drug tablets, and a as food additive in
many processed foods. There are few studies in the literature on NPs using gene mutation approaches in
mammalian cells, which represents an important gap for genotoxic risk estimations. To ﬁll this gap, the
mouse lymphoma L5178Y/Tk+/− assay (MLA) was used to evaluate the mutagenic effect for ﬁve different
concentrations (from 0.01 to 150 g/mL) of two different sizes of SAS NPs (7.172 and 7.652 nm) and a
ﬁne collodial form of silicon dioxide (SiO2 ). This assay detects a broad spectrum of mutational events,
from point mutations to chromosome alterations. The results obtained indicate that the two selected
SAS NPs are mutagenic in the MLA assay, showing a concentration-dependent effect. The relative mutagenic potencies according to the induced mutant frequency (IMF) are as follows: SAS NPs (7.172 nm)
(IMF = 705.5 × 10−6 ), SAS NPs (7.652 nm) (IMF = 575.5 × 10−6 ), and SiO2 (IMF = 57.5 × 10−6 ). These in vitro
results, obtained from mouse lymphoma cells, support the genotoxic potential of NPs as well as focus the
discussion of the beneﬁts/risks associated with their use in different areas.
© 2016 Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

1. Introduction
Nanomaterials (NMs) are described as particles, which have a
maximum size of 100 nm or less and exhibit novel physicochemical properties including high tensile strength, thermal and chemical
stability, high hydrophobicity, heat and electrical insulation, hydrogen storage capacity, resistance to oxidation, etc. NMs are at the
leading edge of the rapidly developing ﬁeld of nanotechnology. The
use of nanotechnology has surged in recent years, and the increasing applications of NMs in diverse ﬁelds, such as energy, electronics,
food and agriculture, biomedical devices, imaging, bio-sensing
and chips, environmental clean-up, household products, paints,
consumer products, sports biotechnology, life sciences, medicine,
defence, and engineering [1] have raised awareness of the potential
toxicity of NMs. These particles, by virtue of their size could enter
the body through various routes such as oral, inhalation, absorption, or injection in medical procedures. There is concern about
the potential side effects of these substances on human health
and various studies have been performed revealing these biolog-
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ical effects. Thus, studies in nano-genotoxicology to evaluate the
harmful effects of NMs are increasing [2–6].
Synthetic amorphous silica nanoparticles (SAS NPs) are used
as a food additive in many processed foods, in pharmaceutical
drug tablets, glass, electronics, and in hydrophobic anticancer
drugs [7]. Silica (SiO2 ) NPs induce inﬂammatory and oxidative
stress responses both in vivo and in vitro [8,9], but cytotoxicity
has only been observed at high concentrations [10]. Wang et al.
[11] demonstrated that ultraﬁne SiO2 NPs are cytotoxic and genotoxic in cultured human lymphoblastoid cells. SiO2 NPs also have
been reported to impact nuclear integrity by forming intranuclear
protein aggregates that can lead to inhibition of replication, transcription and cell proliferation [12].
Although several studies dealing with the genotoxic properties
of SAS NPs have been carried out, only one study on the mutagenic
potential of nano-silica powder (10 nm) in L5178Y cells has been
reported [13]. For this reason, we used the mouse lymphoma assay
(MLA) as an in vitro mutagenicity test system [14–20].
The MLA has been applied to the mouse lymphoblastic cell line
for in vitro mutagenicity testing of different mutational changes,
including mitotic recombination, point mutations, chromosome
aberrations, and aneuploidy [21,22], including NMs [13,19]. These
features make the MLA particularly useful to evaluate the ability of
chemicals to induce a wide variety of mutational events [16,22].

http://dx.doi.org/10.1016/j.toxrep.2016.10.006
2214-7500/© 2016 Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In this study, the MLA was used to assess the genotoxicity of
two different sizes of SAS NPs in a mouse lymphoma cell line. The
MLA provides both rapid and reliable data on the genotoxicity of
chemicals. The thymidine kinase (Tk) locus has been widely used
to detect the ability of chemicals to induce genetic damage in cultured mammalian cells. Taking into account that particle structure
and size can be an important modulating agent, our study included
two different size ranges for the SAS NPs (7.172 and 7.652 nm). In
addition, we also included a ﬁne colloidal SiO2 to determine the
importance of particle size in the observed effects.
2. Materials and methods
2.1. Chemicals
SiO2 NPs aqueous dispersion, amorphous, 25 wt%, 5–35 nm
(99.99% purity; CAS No. 13463-67-7, US7300) and SiO2 NPs aqueous dispersion, amorphous, 25 wt%, 30 nm (99.99% purity; CAS
No. 13463-67-7, US7040) were from US Research Nanomaterials,
Inc. Both SiO2 NPs were in amorphous form. Fine size collodial,
40 wt% suspension in H2 O silicon dioxide (CAS No. 7631-86-9) was
from Sigma Chemicals Co. (St. Louis, MO, USA). Methyl methanesulfonate (MMS, 99% purity; CAS No. 66-27-3), ethanol (≥99.5%
purity; CAS No. 64-17-5), bovine serum albumin (BSA, ≥98% purity;
CAS No. 9048-46-8), thiazolyl blue tetrazolium bromide (MTT,
99.7% purity; CAS No. 298-93-1), triﬂuorothymidine (≥99% purity;
CAS No. 70-00-8), thymidine (CAS No. 4449-43-8), hypoxanthine
(99% purity; CAS No. 68-94-0), methotrexate (CAS No. 59-05-2)
and glycine (≥99% purity; CAS No. 56-40-6) were obtained from
Sigma-Aldrich Chemie GmbH (Steinheim, Germany). RPMI 1640
medium, horse serum, L-glutamine solution (CAS No. 56-85-9),
penicillin/streptomycin solution, sodium pyruvate solution (CAS
No. 113-24-6) and amphotericin B solution (CAS No. 1397-89-3)
were purchased from PAA Laboratories (Pasching, Austria).
2.2. Nanoparticles characterization and dispersion procedure
To characterize the selected NPs different analyses using transmission electron microscopy (TEM), dynamic light scattering (DLS),
and laser Doppler velocimetry (LDV) methodologies were carried out. TEM methodologies were carried on a Tecnai G2 F30
instrument to determine size and morphology. DLS and LDV were
performed on a Malvern Zetasizer Nano-ZS zen3600 instrument
for the characterization of hydrodynamic size and zeta potential. For dispersion, NPs were pre-wetted in 0.5% absolute ethanol
and afterwards dispersed in 0.05% bovine serum albumin (BSA) in
MilliQ water. The NPs in the dispersion medium were sonicated for
16 min to obtain a stock dispersion of 2.56 mg/mL according to the
Nanogenotox protocol [23].
2.3. Mouse lymphoma assay (MLA)
The L5178Y/Tk+/− -3.7.2C mouse lymphoma cell line was used
for the mutation assay. Cells were cultured in suspension in RPMI
1640 medium supplemented with 10% vol/vol DHS, L-glutamine
(2 mM), penicillin (100 U/mL), streptomycin (100 g/mL), sodium
pyruvate (1 mM) and amphotericin B (2.5 g/mL). Cultures were
routinely diluted to 2 × 105 cells/mL daily to prevent overgrowth
( > 106 cells/mL).
Detailed procedures and current guidance for conduct of the
MLA are given elsewhere [15,24,25]. In brief, the assay was performed using liquid medium and limiting-dilution cloning in
96-well plates without S9exogenous metabolic activation according to the method previously described by us [17,18,20]. Cells
were treated with different concentrations (ranging from 0.01 to
150 g/mL) of the two different sizes of SAS NPs and the ﬁne

sized form in RPMI 1640 medium with 10% heat-inactivated horse
serum for 4 h at 37 ◦ C. MMS was dissolved in distilled water, and
10 g/mL was used as positive control. Cells were counted by using
an automatic cell counter, and densities were adjusted using fresh
medium at approximately 2 d after exposure. For mutant enumeration, triﬂuorothymidine (TFT) was added to the cell culture at a
ﬁnal concentration of 4 g/mL, and cells were seeded onto 96-well
ﬂat-bottom microtiter plates. All plates were incubated at 37 ◦ C in
a humidiﬁed incubator with 5% CO2 in air. After 12 d of incubation,
colonies were counted and categorized as small or large [17,18].
A small colony was deﬁned as a colony having a size of ≤ onefourth of the well diameter. On the other hand, large colonies were
those larger than 25% of the well diameter. Mutant frequencies,
percentages of small and large mutant colonies, and cytotoxicity
were determined.
Different concentrations of SAS NPs (0.01, 1, 10, 100 and
150 g/mL) were chosen based on preliminary studies in the literature [13,26–28]. Preliminary experiments were conducted to
determine the cytotoxicity of SAS NPs and theirs ionic forms. Cytotoxicity was determined by the relative total growth (RTG). RTG
measures cytotoxicity including cell growth during treatment (4 h),
expression (2 d), and cloning (12 d). RTG measurement takes into
account cell loss after treatment, reduction in growth rate over
the expression period, and any reduction in cloning efﬁciency on
the day of selection for mutants [21]. The recommended highest
concentration was one that corresponded with an RTG of 20% or
more than 20% [29]. Therefore, the ﬁnal concentrations of the test
chemicals in the main experiments were 0.01–150 g/mL.
2.4. Statistical analysis
The criteria of the Mouse Lymphoma Assay Workgroup of the
International Workshop on Genotoxicity Tests (IWGT) were applied
to determine whether a response was positive or negative [24].
IWGT considers biological relevance to be a major factor in MLA
data evaluation that requires that the induced mutant frequency
(IMF) exceeds some value based on the global background mutant
frequency (MF). This value is the global evaluation factor (GEF),
which is considered to be 126 for the micro-well version. The IMF
is obtained by MF-SMF = IMF, where MF is one of the test-culture
mutant frequencies, and SMF is the spontaneous mutant frequency.
Positive responses are those which, for any treatment meet or
exceed the GEF plus vehicle control MF, and exhibit a positive
trend test as well. The statistical approach was the one-way ANOVA
followed by Dunnett’s test, which was used to evaluate the signiﬁcance of the difference in MF between control and treatments. The
concentration-response relationship was also evaluated by testing
for a linear trend [30]. The level of statistical signiﬁcance was set
at 5%. Each compound was tested in two independent experiments
and a good concordance was observed between both experiments.
3. Results
3.1. NPs characterization
This study used TEM to determine particle size of SAS NPs
(7.172 nm) and SAS NPs (7.652 nm). Examples of TEM ﬁgures are
shown in Figs. 1A 2A . Information on mean size and standard
deviation was calculated by measuring 200 isolated NPs in random areas. As observed, the obtained measures match well with
those indicated by the manufacturer: 7.08 ± 3.126 for SAS NPs
(7.172 nm) and8.04 ± 5.738 for SAS NPs (7.652 nm). The average
hydrodynamic diameter and zeta potential of the SAS NPs suspensions in RPMI 1640 medium with 10% DHS were detected by DLS
and LVD, respectively. Later, the sonicated NPs were dispersed in
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Table 1
Results of the toxicity and mutagenicity of ﬁne SiO2 in mouse lymphoma cells (L5178Y/Tk+/− -3.7.2C) after 4 h of exposure.
Concentration (g/mL)

Percent plating efﬁciency

Mutant frequency (×10−6 )

Relative total growth

MF (S/L)a (×10−6 )

IMF (MF-SMF)

Experiment 1
0
0.01
1
10
100
150
MMS (10 g/mL)

91
88
82
80
77
75
66

70
79
99
95
114
134
670***

100
92
82
63
53
46
51

58/12
79/0
86/13
70/25
70/44
80/54
542/128

–
9
29
25
44
64
600

Experiment 2
0
0.01
1
10
100
150
MMS (10 g/mL)

91
85
80
78
75
74
80

60
68
88
89
109
111
607***

100
85
76
69
59
49
50

60/0
65/3
73/15
68/21
67/42
73/38
470/137

–
8
28
29
49
51
547

***
a

P ≤ 0.001 (Signiﬁcantly different from negative control).
Total mutant frequency divided into small/large (S/L) colony mutant frequencies.

RPMI 1640 medium with 10% DHS for the genotoxic measurements.
The average diameters obtained using DLS were 7.172 ± 1.774 and
7.652 ± 1.906 nm for SAS NPs (7.172 and 7.652 nm, respectively)
(Figs. 1B 2B). The hydrodynamic diameter averages were similar to
TEM analyses, indicating good dispersion. The zeta potential average obtained from the LDV technique was −45.9 and −58.4 mV
for SAS NPs (7.172 and 7.652 nm, respectively), (Figs. 1C 2C). This
highly negative surface charge results in good stability and dispersion of these nano-compounds in a medium solution. Energy

dispersive X-rays microanalysis (EDX) shows the expected Si and
O peaks for the SAS NPs in the dispersion solution (Figs. 1D 2D).
3.2. Mutagenicity as detected by the MLA
The genotoxic potentials of SAS NPs and ﬁne collodial SiO2 were
assessed at various concentrations in the MLA. The results obtained
after treatment of the cells with SAS NPs and SiO2 are indicated
in Tables 1–3 and Figs. 3–5, respectively. Each compound was
tested in two experiments with two replicates. Prior to use, SAS

Fig. 1. Characterization of SAS NPs (7.172 nm). (A) Typical TEM image and size distribution histogram using such images. (B) and (C) represents size distribution and zeta
potential, by DLS and LDV characterization. (D) Energy dispersive X-rays microanalysis (EDX) spectrum shows the chemical composition of SAS NPs (7.172 nm) in the
dispersion solution.
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Fig. 1. (Continued)

NPs and SiO2 were dispersed in distilled water containing 0.05%
BSA. This suspension solution was used as the negative control.
MMS (10 g/mL), which was used as a positive control, showed
a strong mutagenic effect. The negative control mutant frequency
was in good agreement with the normal background range previously reported [18,20]. Signiﬁcant increases were observed for the
positive controls carried out using 10 g/mL of MMS, which would
support the validity of both the results observed and the protocols
used.
Tables 1–3 summarizes the results of the MLA after exposure of
L5178Y cells to SAS NPs and ﬁne SiO2 at ﬁve concentrations for 4 h.

In this study, the ﬁne form of SiO2 (Table 1 and Fig. 3) was tested
from 0.01 to 150 g/mL. Although slight increases were observed
after ﬁne colloidal SiO2 exposure, it did not cause a signiﬁcant mutagenic response in the MLA assay, and the cytotoxicity test did not
show any viability reduction (taking into account the RTG values)
after exposure to up to150 g/mL ﬁne SiO2 ) (Table 1). In other
words, the results demonstrated that ﬁne SiO2 at the concentrations tested was not genotoxic in this assay.
When SAS NPs (7.172 and 7.652 nm) were tested for the induction of mutagenicity in the MLA, signiﬁcant mutagenic effects were
observed (Tables 2 and 3 and Figs. 4 and 5). RTG values were used

E. Demir, V. Castranova / Toxicology Reports 3 (2016) 807–815
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Table 2
Results of the toxicity and mutagenicity of SAS NPs (7.172 nm) in mouse lymphoma cells (L5178Y/Tk+/− -3.7.2C) after 4 h of exposure.
Concentration (g/mL)

Percent plating efﬁciency

Mutant frequency (×10−6 )

Relative total growth

MF (S/L)a (×10−6 )

IMF (MF-SMF)

Experiment 1
0
0.01
1
10
100
150
MMS (10 g/mL)

95
88
76
74
67
62
61

64
76
104
115
449***
785***
879***

100
87
66
58
45
36
55

64/0
60/16
74/30
73/42
309/140
588/197
698/181

–
12
40
51
385
721
815

Experiment 2
0
0.01
1
10
100
150
MMS (10 g/mL)

98
93
81
75
70
63
61

62
72
97
122
500***
752***
808***

100
86
69
53
44
35
49

48/14
54/18
66/31
76/46
395/105
535/217
620/188

–
10
35
60
438
690
746

***
a

P ≤ 0.001 (Signiﬁcantly different from negative control).
Total mutant frequency divided into small/large (S/L) colony mutant frequencies.

to determine the toxicity at each concentration level. Thereby, the
selected ranges for SAS NPs, taking into account the obtained RTG
values, were 0–150 g/mL (Tables 2–3). At concentrations higher
than 10 g/mL, distinct decreases in the relative total growth (RTG)
were found and the two highest tested doses (100 and 150 g/mL)
were clearly mutagenic. The data suggest that SAS NPs may cause

mutagenicity and damage at the chromosomal level in the MLA.
The relative mutagenic potency according to the induced mutant
frequency (IMF) was 705.5 × 10−6 at the highest concentration of
SAS NPs (7.172 nm) and 575.5 × 10−6 at the highest concentration of SAS NPs (7.652 nm). According to these results, we selected
150 g/mL for the ﬁnal concentration of SAS NPs in the MLA exper-

Fig. 2. Characterization of SAS NPs (7.652 nm). (A) Typical TEM image and size distribution histogram using such images. (B) and (C) represents size distribution and zeta
potential, by DLS and LDV characterization. (D) Energy dispersive X-rays microanalysis (EDX) spectrum shows the chemical composition of SAS NPs (7.652 nm) in the
dispersion solution.
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Fig. 2. (Continued)

iments. Above this concentration, the RTG was lower than 20%,
which is usually accepted as the maximum level of toxicity for MLA.
4. Discussion
The use of MLA in the evaluation of mutagenicity has been
well established as a genotoxicity test-system. In this context, we
present studies using the MLA assay to extend our knowledge of
the potential genotoxic risk of SAS NPs.

Several studies in the literature have demonstrated that some
NMs are toxic and cytotoxic, with some NPs inducing allergic or
inﬂammatory responses [6]. It is assumed that some NMs can generate reactive oxygen species (ROS), inducing oxidative stress, DNA
damage, micronucleus formation, inﬂammatory events and ﬁbrosis in different target organs [31]. Nevertheless, NMs’ toxic effects
depend on their unique physicochemical properties, such as form,
size, chemical stability, dissolution rate, coating, surface charge,
agglomerations/aggregations, crystal structure, and size [32,33].

E. Demir, V. Castranova / Toxicology Reports 3 (2016) 807–815

813

Table 3
Results of the toxicity and mutagenicity of SAS NPs (7.652 nm) in mouse lymphoma cells (L5178Y/Tk+/− -3.7.2C) after 4 h of exposure.
Concentration (g/mL)

Percent plating efﬁciency

Mutant frequency (×10−6 )

Relative total growth

MF (S/L)a (×10−6 )

IMF (MF-SMF)

Experiment 1
0
0.01
1
10
100
150
MMS (10 g/mL)

95
87
78
69
62
56
60

71
74
85
123
554**
680***
661***

100
85
69
53
45
37
47

71/0
74/0
82/3
86/37
448/106
548/132
492/169

–
3
14
52
483
609
590

Experiment 2
0
0.01
1
10
100
150
MMS (10 g/mL)

95
80
71
69
62
55
50

61
73
110
105
475***
603***
808***

100
75
54
43
34
26
33

61/0
73/0
95/15
80/25
364/111
454/149
652/156

–
12
49
44
414
542
747

**
***
a

P ≤ 0.01.
P ≤ 0.001 (Signiﬁcantly different from negative control).
Total mutant frequency divided into small/large (S/L) colony mutant frequencies.

Fine Collodial Silica (SiO2)
Mutant Frequency
(x10-6)

800

600
Experiment 1
400
Experiment 2
200

0
0

0.01

1

10

100

150

MMS

Concentration (µg/mL)
Fig. 3. Mutation frequencies for ﬁne colloidal silica (SiO2 ), on L5178Y/Tk+/− mouse lymphoma cells. Positive control (MMS, 10 g/mL). Results are from two different
experiments with two replicates each.

SAS NPs (7.172 nm)

Mutant Frequency
(x10-6)

1000
800
600

Experiment 1

400

Experiment 2

200
0
0

0.01

1

10

100

150

MMS

Concentration (μg/mL)
Fig. 4. Mutation frequencies for SAS NPs (7.172 nm), on L5178Y/Tk+/− mouse lymphoma cells. Positive control (MMS, 10 g/mL). Results are from two different experiments
with two replicates each.

NMs can easily enter the cell membrane and accumulate in the cytoplasm, disrupt metabolism, and induce cell death [34]. SAS NPs may
play a role in a variety of effects, such as mitochondrial dysfunction, oxidative stress, lipid peroxidation, and cell death by direct or
indirect mechanisms [35–37].

At present there is limited evidence concerning whether or
not SAS are genotoxic, with contradictory results being reported
[38,39]. Choi et al. [13] demonstrated no mutagenicity of nanosilica (10 nm) using the MLA in L5178Y/Tk+/− mouse lymphoma
cells in the absence or presence of S-9 activation for 3 h. In contrast, SAS NPs did show mutagenicity at the highest concentrations
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SAS NPs (7.652 nm)
Mutant Frequency
(x10-6)

1000
800
600
Experiment 1
400
Experiment 2
200
0
0

0.01

1

10

100

150

MMS

Concentration (μg/mL)
Fig. 5. Mutation frequencies for SAS NPs (7.652 nm), on L5178Y/Tk+/− mouse lymphoma cells. Positive control (MMS, 10 g/mL). Results are from two different experiments
with two replicates each.

(100 and 150 g/mL) for 4 h in the same cell line according to our
ﬁndings. It is not clear why results of these studies differ. However,
it should be noted that a high degree of dispersion was achieved in
the present study without use of chemical dispersants.
In vitro studies conducted to detect chromosome damage induction have reported positive effects for 80 nm SAS NPs in 3T3-L1
mouse ﬁbroblasts in the micronucleus assay [40], but no effects
were observed in the same assay using Balb/3T3 mouse ﬁbroblasts with SAS NPs having diameters ranging from 15 to 300 nm
[41] and with human lymphocytes for 15 and 55 nm SAS NPs [42].
When the induction of primary DNA damage was assayed using
the Comet assay negative results were reported in 3T3-L1 mouse
ﬁbroblasts [43] and in A549 human lung carcinoma cells [44]. In
contrast, positive effects have been obtained in human lung alveolar (A549) epithelial cells with 20 and 100 nm SAS NPs [45], as well
as in human umbilical vein endothelial cells [46], in human peripheral blood lymphocytes and cultured human embryonic kidney
(HEK293) cells using 6, 15, 30, and 55 nm SAS NPs with and without
formamidopyrimidine DNA N-glycosylase (Fpg) and endonuclease
III (Endo III) enzymes [26], and in L5178Y and BEAS–2 B cells for
10 nm SAS NPs [13]. In another study, Gerloff et al. [47] showed
that amorphous fumed nano-silica (14 nm) administration for 24 h
caused DNA damage and cytotoxicity in the human colon epithelial
cell-line, Caco-2.With respect to SAS NPs toxicity it is assumed that
their toxicity is mediated by oxidative stress, inﬂammatory, and
apoptotic mechanisms, as these responses have been shown in both
in vivo and in vitro [8,9,28,48–50]. However, from the genotoxic
point of view the obtained results are contradictory. Our positive
results suggest that further genotoxicity studies with SAS NPs using
different cell lines and different in vitro assays are warranted.
In the present study, the genotoxic potential of two different
NP sizes of SAS NPs using the MLA was much greater than an
equal mass concentration of ﬁne colloidal silica. Since the ﬁne silica sample was in the micrometer size range (average particle size
(diameter): 12 nm, speciﬁc surface area: 220 m2 /g SiO2 ), on a mass
basis, cells were exposed to a far greater particle number and total
particle surface with SAS NPs than with the ﬁne silica sample. The
greater toxicity of NPs on a mass basis vs. ﬁne particles of the same
composition is well documented [51,52].
In conclusion, results from the present study conﬁrm the usefulness of the MLA in evaluation of the genotoxicity of NPs. The fact
the SAS NPs exhibit a signiﬁcant concentration-dependent mutagenicity indicate that this response should be considered in the
evaluation of the risk/beneﬁts associated use of SAS NPs.
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